Apart from etiology, one possible reason for this discrepancy is that among patients with advanced fibrosis and chronic hepatitis, the serum AFP level can be elevated, so the sensitivity and specificity of AFP are limited [33,34]. This evidence concerns the gene AFP and chronic hepatitis.